Home
Conditions
TDP-43 Proteinopathies

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis

NCT03626012

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Research Site La Jolla, California, United States

Research Site Los Angeles, California, United States

Research Site Palo Alto, California, United States

Research Site Jacksonville, Florida, United States

View all 21 locations

View Trial Details

Completed

Feasibility of Passive Data Collection in Dementia Subjects With Agitation

NCT04413851

Conditions: Alzheimer Disease, Arterial Occlusive Diseases, Arteriosclerosis, +30 more
Locations: Tucson Neuroscience Research, LLC Tucson, Arizona, United States

Virtual Research Site New York, United States

View Trial Details

Completed

Ultrasonography of the Neuromuscular Degeneration Behavior in Amyotrophic Lateral Sclerosis

NCT03683875

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Hospital General Universitario Santa Lucia Cartagena, Murcia, Spain

View Trial Details

Completed

Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT02238626

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Carolinas Healthcare System, Dept. of Neurology Charlotte, North Carolina, United States

View Trial Details

Completed

ALS and Airway Clearance (ALSAC) Therapy

NCT04947436

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
Locations: University of Texas Health San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Italian Validation of the Beaumont Behavioural Inventory (BBI)

NCT04440644

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: ICS Maugeri Milan, Italy

View Trial Details

Completed

The Relationship Between Arterial Stiffness and Respiratory Failure in Motor Neurone Disease

NCT03444428

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Hypoxemia and/or Hypercapnia, +10 more
Locations: Guys and St Thomas NHS Trust London, United Kingdom

Royal Brompton and Harefield NHS Trust London, United Kingdom

View Trial Details

Completed

Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis

NCT03427086

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: American univeristy of Beirut medical center Beirut, Lebanon

View Trial Details

Completed

Brown Adipose Tissue in ALS

NCT03150290

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Paris Als Center, Salpetriere Hospital Paris, France

View Trial Details

Completed

Olfactory Deficits in Neurologic Disease

NCT05019014

Conditions: Alzheimer Disease, Amyotrophic Lateral Sclerosis, Basal Ganglia Diseases, +30 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

TDP-43 Proteinopathies

TDP-43 Proteinopathies trial results

Related conditions